Literature DB >> 22951442

HIV pathogenesis: the host.

A A Lackner1, Michael M Lederman, Benigno Rodriguez.   

Abstract

Human immunodeficiency virus (HIV) pathogenesis has proven to be quite complex and dynamic with most of the critical events (e.g., transmission, CD4(+) T-cell destruction) occurring in mucosal tissues. In addition, although the resulting disease can progress over years, it is clear that many critical events happen within the first few weeks of infection when most patients are unaware that they are infected. These events occur predominantly in tissues other than the peripheral blood, particularly the gastrointestinal tract, where massive depletion of CD4(+) T cells occurs long before adverse consequences of HIV infection are otherwise apparent. Profound insights into these early events have been gained through the use of nonhuman primate models, which offer the opportunity to examine the early stages of infection with the simian immunodeficiency virus (SIV), a close relative of HIV that induces an indistinguishable clinical picture from AIDS in Asian primate species, but importantly, fails to cause disease in its natural African hosts, such as sooty mangabeys and African green monkeys. This article draws from data derived from both human and nonhuman primate studies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22951442      PMCID: PMC3426821          DOI: 10.1101/cshperspect.a007005

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  200 in total

1.  HIV-associated nephropathy.

Authors:  Michael J Ross; Paul E Klotman
Journal:  AIDS       Date:  2004-05-21       Impact factor: 4.177

2.  Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load.

Authors:  Steven G Deeks; Christina M R Kitchen; Lea Liu; Hua Guo; Ron Gascon; Amy B Narváez; Peter Hunt; Jeffrey N Martin; James O Kahn; Jay Levy; Michael S McGrath; Frederick M Hecht
Journal:  Blood       Date:  2004-04-29       Impact factor: 22.113

3.  HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control.

Authors:  Brinda Emu; Elizabeth Sinclair; Hiroyu Hatano; April Ferre; Barbara Shacklett; Jeffrey N Martin; J M McCune; Steven G Deeks
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

4.  CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection.

Authors:  Jason V Baker; Grace Peng; Joshua Rapkin; Donald I Abrams; Michael J Silverberg; Rodger D MacArthur; Winston P Cavert; W Keith Henry; James D Neaton
Journal:  AIDS       Date:  2008-04-23       Impact factor: 4.177

5.  Classic AIDS in a sooty mangabey after an 18-year natural infection.

Authors:  Binhua Ling; Cristian Apetrei; Ivona Pandrea; Ronald S Veazey; Andrew A Lackner; Bobby Gormus; Preston A Marx
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

6.  Cancer risk in people infected with human immunodeficiency virus in the United States.

Authors:  Eric A Engels; Robert J Biggar; H Irene Hall; Helene Cross; Allison Crutchfield; Jack L Finch; Rebecca Grigg; Tara Hylton; Karen S Pawlish; Timothy S McNeel; James J Goedert
Journal:  Int J Cancer       Date:  2008-07-01       Impact factor: 7.396

7.  Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut.

Authors:  Manuela Raffatellu; Renato L Santos; David E Verhoeven; Michael D George; R Paul Wilson; Sebastian E Winter; Ivan Godinez; Sumathi Sankaran; Tatiane A Paixao; Melita A Gordon; Jay K Kolls; Satya Dandekar; Andreas J Bäumler
Journal:  Nat Med       Date:  2008-03-23       Impact factor: 53.440

8.  Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy.

Authors:  Tae-Wook Chun; David C Nickle; Jesse S Justement; Jennifer H Meyers; Gregg Roby; Claire W Hallahan; Shyam Kottilil; Susan Moir; Joann M Mican; James I Mullins; Douglas J Ward; Joseph A Kovacs; Peter J Mannon; Anthony S Fauci
Journal:  J Infect Dis       Date:  2008-03-01       Impact factor: 5.226

9.  Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection.

Authors:  Saurabh Mehandru; Michael A Poles; Klara Tenner-Racz; Patrick Jean-Pierre; Victoria Manuelli; Peter Lopez; Anita Shet; Andrea Low; Hiroshi Mohri; Daniel Boden; Paul Racz; Martin Markowitz
Journal:  PLoS Med       Date:  2006-12       Impact factor: 11.069

10.  Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis.

Authors:  Nicholas Funderburg; Angel A Luciano; Wei Jiang; Benigno Rodriguez; Scott F Sieg; Michael M Lederman
Journal:  PLoS One       Date:  2008-04-02       Impact factor: 3.240

View more
  35 in total

1.  Particular activation phenotype of T cells expressing HLA-DR but not CD38 in GALT from HIV-controllers is associated with immune regulation and delayed progression to AIDS.

Authors:  Sandra M Gonzalez; Natalia A Taborda; Luis A Correa; Gustavo A Castro; Juan C Hernandez; Carlos J Montoya; Maria T Rugeles
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

Review 2.  Purinergic signaling and human immunodeficiency virus/acquired immune deficiency syndrome: From viral entry to therapy.

Authors:  Daniela F Passos; Maria Rosa C Schetinger; Daniela Br Leal
Journal:  World J Virol       Date:  2015-08-12

3.  Immune Control of HIV.

Authors:  Muthukumar Balasubramaniam; Jui Pandhare; Chandravanu Dash
Journal:  J Life Sci (Westlake Village)       Date:  2019-06

4.  HIV-1 pathogenesis: the virus.

Authors:  Ronald Swanstrom; John Coffin
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

Review 5.  Genetic variation and HIV-associated neurologic disease.

Authors:  Satinder Dahiya; Bryan P Irish; Michael R Nonnemacher; Brian Wigdahl
Journal:  Adv Virus Res       Date:  2013       Impact factor: 9.937

6.  Increased stability and limited proliferation of CD4+ central memory T cells differentiate nonprogressive simian immunodeficiency virus (SIV) infection of sooty mangabeys from progressive SIV infection of rhesus macaques.

Authors:  Colleen S McGary; Barbara Cervasi; Ann Chahroudi; Luca Micci; Jessica Taaffe; Tracy Meeker; Guido Silvestri; Miles P Davenport; Mirko Paiardini
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

7.  Fusion Stage of HIV-1 Entry Depends on Virus-Induced Cell Surface Exposure of Phosphatidylserine.

Authors:  Elena Zaitseva; Eugene Zaitsev; Kamran Melikov; Anush Arakelyan; Mariana Marin; Rafael Villasmil; Leonid B Margolis; Gregory B Melikyan; Leonid V Chernomordik
Journal:  Cell Host Microbe       Date:  2017-07-12       Impact factor: 21.023

Review 8.  Human immunodeficiency virus vaccine trials.

Authors:  Robert J O'Connell; Jerome H Kim; Lawrence Corey; Nelson L Michael
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

9.  HIV pathogenesis: dynamics and genetics of viral populations and infected cells.

Authors:  John Coffin; Ronald Swanstrom
Journal:  Cold Spring Harb Perspect Med       Date:  2013-01-01       Impact factor: 6.915

Review 10.  CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure.

Authors:  Afam A Okoye; Louis J Picker
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.